Search research articles
Contact Us
Filters
Showing results (501-510 of 594) with videos related to
Page
of 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2010
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer
Setsuko K Chambers, Mary C Clouser, Amanda F Baker, et al.
Infection and Immunity
|
November 24, 2004
Regulators encoded in the Escherichia coli type III secretion system 2 gene cluster influence expression of genes within the locus for enterocyte effacement in enterohemorrhagic E. coli O157:H7
Lihong Zhang, Roy R Chaudhuri, Chrystala Constantinidou, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 14, 2018
Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice
Karen Blohm-Mangone, Nichole B Burkett, Shekha Tahsin, et al.
Scientific Reports
|
February 5, 2024
Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid
Billie Bixby, Lukas Vrba, Jyoti Lenka, et al.
JNCI Cancer Spectrum
|
January 23, 2025
Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence
Jennifer W Bea, Heather M Ochs-Balcom, Celina I Valencia, et al.
Journal of the National Cancer Institute
|
August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Patricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Journal of the National Cancer Institute
|
August 18, 2016
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes
Patricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 13, 2012
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention
Patricia Thompson, Denise J Roe, Liane Fales, et al.
Blood
|
July 13, 2014
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma
Paul M Barr, Thomas P Miller, Jonathan W Friedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer
Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, et al.
Page
of 60
Search research articles
Search
Showing results (501-510 of 594) with videos related to
Sort By:
Page
of 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2010
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer
Setsuko K Chambers, Mary C Clouser, Amanda F Baker, et al.
Infection and Immunity
|
November 24, 2004
Regulators encoded in the Escherichia coli type III secretion system 2 gene cluster influence expression of genes within the locus for enterocyte effacement in enterohemorrhagic E. coli O157:H7
Lihong Zhang, Roy R Chaudhuri, Chrystala Constantinidou, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 14, 2018
Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice
Karen Blohm-Mangone, Nichole B Burkett, Shekha Tahsin, et al.
Scientific Reports
|
February 5, 2024
Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid
Billie Bixby, Lukas Vrba, Jyoti Lenka, et al.
JNCI Cancer Spectrum
|
January 23, 2025
Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence
Jennifer W Bea, Heather M Ochs-Balcom, Celina I Valencia, et al.
Journal of the National Cancer Institute
|
August 18, 2016
Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial
Patricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Journal of the National Cancer Institute
|
August 18, 2016
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes
Patricia A Thompson, Erin L Ashbeck, Denise J Roe, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 13, 2012
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention
Patricia Thompson, Denise J Roe, Liane Fales, et al.
Blood
|
July 13, 2014
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma
Paul M Barr, Thomas P Miller, Jonathan W Friedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer
Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, et al.
Page
of 60